Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. [electronic resource] by
- Carr, D F
- Wang, C-W
- Bellón, T
- Ressel, L
- Nwikue, G
- Shrivastava, V
- Bergfeld, W
- Jorgensen, A L
- Chung, W-H
- Pirmohamed, M
Producer: 20200828
In:
The British journal of dermatology vol. 181
Availability: No items available.
|
|
|
7.
|
Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study. [electronic resource] by
- Jones, R P
- Sutton, P
- Greensmith, R M D
- Santoyo-Castelazo, A
- Carr, D F
- Jenkins, R
- Rowe, C
- Hamlett, J
- Park, B K
- Terlizzo, M
- O'Grady, E
- Ghaneh, P
- Fenwick, S W
- Malik, H Z
- Poston, G J
- Kitteringham, N R
Producer: 20130924
In:
Cancer chemotherapy and pharmacology vol. 72
Availability: No items available.
|
|
|
8.
|
Phenotype standardization for statin-induced myotoxicity. [electronic resource] by
- Alfirevic, A
- Neely, D
- Armitage, J
- Chinoy, H
- Cooper, R G
- Laaksonen, R
- Carr, D F
- Bloch, K M
- Fahy, J
- Hanson, A
- Yue, Q-Y
- Wadelius, M
- Maitland-van Der Zee, A H
- Voora, D
- Psaty, B M
- Palmer, C N A
- Pirmohamed, M
Producer: 20141124
In:
Clinical pharmacology and therapeutics vol. 96
Availability: No items available.
|